The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection.

MLA

Ohashi, Ayaka, et al. “The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection.” Frontiers in Microbiology, vol. 13, Apr. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fmicb.2022.874998.

APA

Ohashi, A., Uemura, Y., Yoshimori, M., Wada, N., Imadome, K.-I., Yudo, K., Koyama, T., Shimizu, N., Nishio, M., & Arai, A. (2022). The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection. Frontiers in Microbiology, 13, 1–9. https://doi.org/10.3389/fmicb.2022.874998

Chicago

Ohashi, Ayaka, Yu Uemura, Mayumi Yoshimori, Naomi Wada, Ken-Ichi Imadome, Kazuo Yudo, Takatoshi Koyama, Norio Shimizu, Miwako Nishio, and Ayako Arai. 2022. “The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection.” Frontiers in Microbiology 13 (April): 1–9. doi:10.3389/fmicb.2022.874998.